Microbial biosynthetic enzymes

Microbial biosynthetic enzymes are a broad class of catalytic proteins essential for the growth, maintenance, and reproduction of bacteria, fungi, and other pathogens. These enzymes are responsible for synthesizing vital cellular components such as the peptidoglycan cell wall, essential amino acids, and nucleic acid precursors like folic acid (NCBI, 2023). Because many of these pathways are absent in humans or utilize structurally distinct enzyme isoforms, they are ideal targets for selective antimicrobial agents. For instance, beta-lactam antibiotics target penicillin-binding proteins (PBPs) to disrupt cell wall integrity, while sulfonamides inhibit dihydropteroate synthase in the folate pathway (PubMed, 2022). The clinical utility of targeting these enzymes is often limited by the emergence of drug resistance through mutations or horizontal gene transfer. Furthermore, drug design must account for the potential disruption of the host's beneficial microbiome and avoid cross-reactivity with human metabolic homologs. Modern drug discovery also focuses on non-essential biosynthetic pathways that contribute to virulence or biofilm formation (Nature Reviews Microbiology, 2021). Overall, these enzymes remain the cornerstone of infectious disease pharmacology.

Other names

Microbial metabolic enzymesPathogen biosynthetic enzymesBacterial enzymesFungal biosynthetic enzymes

Inhibition of cell wall peptidoglycan cross-linking, inhibition of dihydropteroate synthase, inhibition of dihydrofolate reductase, inhibition of DNA gyrase and topoisomerase IV, and inhibition of DNA-dependent RNA polymerase.